Description
Lotte & John Hecht Memorial Foundation of Vancouver, BC would like to welcome research groups to apply for funding opportunities in the field of major illnesses with primary focus in oncology. We specialize in providing support to research projects that are novel and innovative and/or that otherwise experience difficulties in receiving support from other sources potentially resulted from inability to create intellectual property, or from lack of peer support – in other words, high risk, unconventional and disruptive research.
Because of that premise, research project must be of high quality. We welcome all spectrum of experimental design initiatives, from meta-analyses and pilots to randomized controlled double-blinded trials and operational support; both pre-clinical and clinical projects are invited, with preference being given to clinical trials.
Currently, applications are reviewed three times per year with potential for funding starting in April, August, and December for successful applicants. For more information, please, emailanakonechnaya [at] hecht.org or visit our website at hecht.org.
Examples of previously funded research include:
-
Lessening organ dysfunction/injury with vitamin C (LOVIT trial) / University of Sherbrooke / ClinicalTrials ID – NCT03680274
-
Phase II randomized cross-over study of the efficacy and safety of omega 3 fatty acid supplements on lung cancer-promoting inflammatory markers in heavy smokers / BC Cancer
-
Histamine receptor 2 antagonists as enhancers of anti-tumor immunity / Dalhousie University, through a collaboration with Canadian Cancer Society
-
Fecal microbial transplantation in combination with immunotherapy in melanoma patients (MIMic trial) / Lawson Health Research Institute / ClinicalTrials ID – NCT03772899